This is a Validated Antibody Database (VAD) review about human FDPS, based on 6 published articles (read how Labome selects the articles), using FDPS antibody in all methods. It is aimed to help Labome visitors find the most suited FDPS antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FDPS synonym: FPPS; FPS; POROK9; farnesyl pyrophosphate synthase; (2E,6E)-farnesyl diphosphate synthase; FPP synthase; FPP synthetase; farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase
Abcam
rabbit polyclonal |
| Abcam FDPS antibody (Abcam, ab-38854) was used in western blot on human samples (fig 1). Cell Death Dis (2015) ncbi |
rabbit polyclonal |
| Abcam FDPS antibody (Abcam, ab38854) was used in western blot on mouse samples . J Diabetes Res (2015) ncbi |
rabbit polyclonal |
| Abcam FDPS antibody (abcam, ab38854) was used in western blot on human samples at 1:1000 (fig 3). Oncotarget (2015) ncbi |
rabbit polyclonal |
| Abcam FDPS antibody (Abcam, ab38854) was used in immunohistochemistry on human samples at 1:100. Br J Cancer (2014) ncbi |
rabbit polyclonal |
| Abcam FDPS antibody (Abcam, ab38854) was used in western blot on mouse samples . J Lipid Res (2014) ncbi |
Invitrogen
rabbit polyclonal |
| In order to analyze the capacity of monocytes, neutrophils, and CD4 T cells to serve as accessory cells for gamma delta T cell activation, Invitrogen FDPS antibody (Thermo Fisher Scientific, PA5-28228) was used in western blot on human samples (fig 6). J Immunol (2016) ncbi |
Articles Reviewed
- Nerdal P, Peters C, Oberg H, Zlatev H, Lettau M, Quabius E, et al. Butyrophilin 3A/CD277-Dependent Activation of Human ?? T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations. J Immunol. 2016;197:3059-3068 pubmed
- Sharon C, Baranwal S, Patel N, Rodriguez Agudo D, Pandak W, Majumdar A, et al. Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo. Oncotarget. 2015;6:15332-47 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments